Explore › Finding
Finding improvement
In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medication type.
Effect sizeHR 0.68
CI95% CI 0.60-0.77
Comparatorsuboptimal glycemic control (HbA1c >=7% for >20% of time)
Effect summaryimprovement; HR 0.68; CI: 95% CI 0.60-0.77

Connected entities

Interventions
Glycemic Control
Conditions
Metastatic hepatocellular carcinoma
Outcomes
Hepatocellular carcinoma
Populations
Type 2 Diabetes Patients

Source

PMC9107529
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
Read on PMC → · View in graph →